AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program

AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program - Yahoo Finance

- August 30, 2019

AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program Yahoo Finance

MERU, a Phase 3 placebo-controlled trial evaluating Rova-T as a first-line maintenance therapy for advanced small-cell lung cancer (SCLC), demonstrated no ...

Search This Blog

Lung Cancer

AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program - Yahoo Finance

Comments

Post a Comment

Popular posts from this blog

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

Not An Ordinary Cough: Lung Cancer Symptoms That You Might Neglect - International Business Times

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago